Answers are grounded in this paper and cite their sources.
The US-based Center of Excellence for Chagas Disease performed an observational study on the safety and tolerance of benznidazole 5 mg/kg/day for 60 days in 30 adults with chronic Chagas disease. The side-effect profile was suboptimal, including 5 cases of debilitating neuropathy and an unusually high angioedema rate.
No takes yet. Share an insight, caveat, or question.
Miller et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: